153 related articles for article (PubMed ID: 29430641)
1. Comparative effect of antipsychotics on risk of self-harm among patients with schizophrenia.
Ma CH; Chang SS; Tsai HJ; Gau SS; Chen IM; Liao SC; Chien YL; Hsieh MH; Wu CS
Acta Psychiatr Scand; 2018 Apr; 137(4):296-305. PubMed ID: 29430641
[TBL] [Abstract][Full Text] [Related]
2. Comparative risk of self-harm hospitalization amongst depressive disorder patients using different antidepressants: a population-based cohort study in Taiwan.
Wu CS; Liao SC; Tsai YT; Chang SS; Tsai HJ
Psychol Med; 2017 Jan; 47(1):81-92. PubMed ID: 27659718
[TBL] [Abstract][Full Text] [Related]
3. Mortality and Self-Harm in Association With Clozapine in Treatment-Resistant Schizophrenia.
Wimberley T; MacCabe JH; Laursen TM; Sørensen HJ; Astrup A; Horsdal HT; Gasse C; Støvring H
Am J Psychiatry; 2017 Oct; 174(10):990-998. PubMed ID: 28750580
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effectiveness of brand-name and generic antipsychotic drugs for treating patients with schizophrenia in Taiwan.
Hsu CW; Lee SY; Wang LJ
Schizophr Res; 2018 Mar; 193():107-113. PubMed ID: 28629889
[TBL] [Abstract][Full Text] [Related]
5. Comparative risk of seizure with use of first- and second-generation antipsychotics in patients with schizophrenia and mood disorders.
Wu CS; Wang SC; Yeh IJ; Liu SK
J Clin Psychiatry; 2016 May; 77(5):e573-9. PubMed ID: 27249081
[TBL] [Abstract][Full Text] [Related]
6. Time to Discontinuation of Second-Generation Antipsychotics Versus Haloperidol and Sulpiride in People With Schizophrenia: A Naturalistic, Comparative Study.
Chan HY; Pan YJ; Chen JJ; Chen CH
J Clin Psychopharmacol; 2017 Feb; 37(1):13-20. PubMed ID: 27977467
[TBL] [Abstract][Full Text] [Related]
7. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
8. Comparative Effectiveness of Antipsychotic Drugs for Rehospitalization in Schizophrenia-A Nationwide Study With 20-Year Follow-up.
Taipale H; Mehtälä J; Tanskanen A; Tiihonen J
Schizophr Bull; 2018 Oct; 44(6):1381-1387. PubMed ID: 29272458
[TBL] [Abstract][Full Text] [Related]
9. Comparison of treatment effectiveness and medical costs for different long-acting injectable antipsychotics in patients with schizophrenia in Taiwan: A nationwide population-based cohort study.
Wu CS; Cheng IC; Feng J; Chen CL
Schizophr Res; 2016 May; 173(1-2):37-44. PubMed ID: 26987938
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic drug use and the risk of seizures: follow-up study with a nested case-control analysis.
Bloechliger M; Rüegg S; Jick SS; Meier CR; Bodmer M
CNS Drugs; 2015 Jul; 29(7):591-603. PubMed ID: 26242478
[TBL] [Abstract][Full Text] [Related]
11. Effect of Clozapine vs Other Second-Generation Antipsychotics on Hospitalization and Seclusion: A Retrospective Mirror-Image Study in a Japanese Public Psychiatric Hospital.
Misawa F; Suzuki T; Fujii Y
J Clin Psychopharmacol; 2017 Dec; 37(6):664-668. PubMed ID: 29045304
[TBL] [Abstract][Full Text] [Related]
12. Association of Aripiprazole With the Risk for Psychiatric Hospitalization, Self-harm, or Suicide.
Montastruc F; Nie R; Loo S; Rej S; Dell'Aniello S; Micallef J; Suissa S; Renoux C
JAMA Psychiatry; 2019 Apr; 76(4):409-417. PubMed ID: 30698607
[TBL] [Abstract][Full Text] [Related]
13. A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia.
Tiihonen J; Haukka J; Taylor M; Haddad PM; Patel MX; Korhonen P
Am J Psychiatry; 2011 Jun; 168(6):603-9. PubMed ID: 21362741
[TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness of long-acting injectable risperidone vs. long-acting injectable first-generation antipsychotics in bipolar disorder.
Wu CS; Hsieh MH; Tang CH; Chang CJ
J Affect Disord; 2016 Jun; 197():189-95. PubMed ID: 26994437
[TBL] [Abstract][Full Text] [Related]
15. Antipsychotic drugs and risk of newly diagnosed tuberculosis in schizophrenia.
Liu HC; Hung GC; Yang SY; Liao YT; Pan CH; Chen CC; Kuo CJ
Psychiatry Clin Neurosci; 2018 Oct; 72(10):789-800. PubMed ID: 29987915
[TBL] [Abstract][Full Text] [Related]
16. Maximizing response to first-line antipsychotics in schizophrenia: a review focused on finding from meta-analysis.
Smith RC; Leucht S; Davis JM
Psychopharmacology (Berl); 2019 Feb; 236(2):545-559. PubMed ID: 30506237
[TBL] [Abstract][Full Text] [Related]
17. Use of antipsychotics and risk of cerebrovascular events in schizophrenic patients: a nested case-control study.
Hsieh PH; Hsiao FY; Gau SS; Gau CS
J Clin Psychopharmacol; 2013 Jun; 33(3):299-305. PubMed ID: 23609396
[TBL] [Abstract][Full Text] [Related]
18. Association Between Antipsychotic Treatment and Advanced Diabetes Complications Among Schizophrenia Patients With Type 2 Diabetes Mellitus.
Wu CS; Gau SS
Schizophr Bull; 2016 May; 42(3):703-11. PubMed ID: 26721264
[TBL] [Abstract][Full Text] [Related]
19. Comparative Effectiveness of Antipsychotics for Risk of Attempted or Completed Suicide Among Persons With Schizophrenia.
Taipale H; Lähteenvuo M; Tanskanen A; Mittendorfer-Rutz E; Tiihonen J
Schizophr Bull; 2021 Jan; 47(1):23-30. PubMed ID: 33428766
[TBL] [Abstract][Full Text] [Related]
20. History of suicidal behavior and clozapine prescribing among people with schizophrenia in China: a cohort study.
Yin Y; Lin C; Wei L; Tong J; Huang J; Tian B; Tan S; Wang Z; Yang F; Tong Y; Chen S; Hong LE; Tan Y
BMC Psychiatry; 2024 Jun; 24(1):440. PubMed ID: 38867174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
